LCB-2151, CAS [[2211175-99-2]] Preis auf Anfrage

Produktübersicht

• Artikelname: LCB-2151, CAS [[2211175-99-2]] Preis auf Anfrage
• Artikelnummer: MCE-HY-175673
• Hersteller Artikelnummer: HY-175673
• Alternativnummer: MCE-HY-175673-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

LCB-2151 (Compound 2), a nucleoside analogue, is an anticancer agent. LCB-2151 disrupts the two primary sources of ATP production (glycolysis and mitochondrial oxidative phosphorylation), reducing the bioenergetic capacity of KRAS-mutated pancreatic cancer cells and inducing ROS formation. LCB-2151 effectively inhibits key enzymes (such as CACT and CPT2) in glycolysis, the TCA cycle and fatty acid beta-oxidation. LCB-2151 has significant cytotoxicity and induces cells apoptosis. LCB-2151 can be used for radiation therapy of cancers research[1].

Produkteigenschaften

• Molekulargewicht: 825.87
• CAS Nummer: [2211175-99-2]
• Formel: C37H43F8N3O5S2
• Target-Kategorie: Apoptosis,Mitochondrial Metabolism,Oxidative Phosphorylation,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound